CECCHI, FRANCO

CECCHI, FRANCO  

AREA CRITICA MEDICO CHIRURGICA (attivo dal 01/01/2000 al 31/12/2012)  

Mostra records
Risultati 1 - 20 di 128 (tempo di esecuzione: 0.059 secondi).
Titolo Data di pubblicazione Autore(i) File
'End-stage' hypertrophic cardiomyopathy: from mystery to model 2007 M.H.Yacoub ; I Olivotto ; F Cecchi
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy 2006 Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; F Cecchi
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 2021 Maurizi N.; Baldi M.; Castelletti S.; Lisi C.; Galli M.; Bianchi S.; Panzera F.; Fumagalli C.; Mochi N.; Parati G.; Olivotto I.; Cecchi F.
An expert consensus document on the management of cardiovascular manifestations of Fabry disease 2020 Linhart A.; Germain D.P.; Olivotto I.; Akhtar M.M.; Anastasakis A.; Hughes D.; Namdar M.; Pieroni M.; Hagege A.; Cecchi F.; Gimeno J.R.; Limongelli G.; Elliott P.
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy 2015 Gajendrarao P.; Krishnamoorthy N.; Selvaraj S.; Girolami F.; Cecchi F.; Olivotto I.; Yacoub M.
ARRHYTHMIAS ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY 2005 BJ. MARON ; I. OLIVOTTO; F. CECCHI
Assessing the need for cardioverter defibrillator implantation in hypertrophic cardiomyopathy: patient association's perspectives 2026 Maurizi, Niccolò; Olivotto, Iacopo; Cecchi, Franco
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy 2008 Olivotto I; Maron MS; Autore C; Lesser JR; Rega L; Casolo G; De Santis M; Quarta G; Nistri S; F Cecchi ; Salton CJ; Udelson JE; Manning WJ; Maron BJ
Beta-Blockers for Prevention of Exercise-induced Left Ventricular Outflow Obstruction in Patients with Hypertrophic Cardiomyopathy 2010 Stefano Nistri; Iacopo Olivotto; Martin S. Maron; Cecilia Ferrantini; Raffele Coppini; Camilla Grifoni; Katia Baldini; Aurelio Sgalambro; Franco Cecchi; Barry J. Maron
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 2024 Rella V.; Maurizi N.; Bernardini A.; Brasca F.M.; Salerno S.; Meda M.; Mariani D.; Torchio M.; Ravaro S.; Cerea P.; Castelletti S.; Fumagalli C.; Conte G.; Auricchio A.; Girolami F.; Pieragnoli P.; Carrassa G.M.; Parati G.; Olivotto I.; Perego G.B.; Cecchi F.; Crotti L.
CARDIOMIOPATIA IPERTROFICA 2008 F. Cecchi; I. Olivotto; S. Nistri
Cardiomiopatie, Miocarditi e Pericarditi 2017 Franco Cecchi, Iacopo Olivotto, Domenico corrado, antonio pelliccia, andrea di lenarda, gianfranco sinagra, massimo lombardi
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 2017 Maurizi N.; Faragli A.; Imberti J.; Briante N.; Targetti M.; Baldini K.; Sall A.; Cisse A.; Berzolari F.G.; Borrelli P.; Avvantaggiato F.; Perlini S.; Marchionni N.; Cecchi F.; Parigi G.; Olivotto I.
CHARACTERISTICS OF MYOCARDIAL HYPERTROPHY IN FRIEDREICH'S ATAXIA. CLINICO-INSTRUMENTAL STUDY IN 10 PATIENTS AND REVIEW OF THE LITERATURE 1987 F. CECCHI; FAVILLI S; SQUILLANTINI G; ZUPPIROLI A; MASINI M; DE SIMONE L; DE SCISCIOLO G; DOLARA A
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. 2008 Elliott P; Andersson B; Arbustini E; Bilinska Z; F Cecchi ; Charron P; Dubourg O; Kühl U; Maisch B; McKenna WJ; Monserrat L; Pankuweit S; Rapezzi C; Seferovic P; Tavazzi L; Keren A
Clinical and genetic features of left ventricular noncompaction: A continuum in cardiomyopathies 2010 Baldi M.; Sgalambro A.; Nistri S.; Girolami F.; Baldini K.; Fantini S.; Grifoni C.; Rega L.; Olivotto I.; Cecchi F.
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 2019 Maurizi N.; Michels M.; Rowin E.J.; Semsarian C.; Girolami F.; Tomberli B.; Cecchi F.; Maron M.S.; Olivotto I.; Maron B.J.
CLINICAL COURSE OF HYPERTROPHIC CARDIOMYOPATHY IN A NON SELECTED POPULATION. EXPERIENCE OF THE ITALIAN MULTICENTER CARDIOMYOPATHY STUDY 1997 F. CECCHI; OLIVOTTO I; LAZZERONI E; CHIRIATTI G; SACHERO A; BERETTA L; GIAGNONI E; RENOSTO G; MONTEREGGI A; BALDASSARRE S; CASTELLI G; CIACCHERI M
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations 2010 Girolami F.; Ho C.Y.; Semsarian C.; Baldi M.; Will M.L.; Baldini K.; Torricelli F.; Yeates L.; Cecchi F.; Ackerman M.J.; Olivotto I.
CLINICAL PROFILE OF STROKE IN 900 PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY 2002 MARON BJ; OLIVOTTO I; BELLONE P; CONTE MR; F. CECCHI; FLYGENRING BP; CASEY SA; GOHMAN TE; BONGIOANNI S; SPIRITO P